Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

Basilea Pharmaceutica Ltd.. (8/14/14). "Press Release: Basilea Reports 2014 Half-year Financials – Ceftobiprole Launch in Germany Planned for Second Half of 2014". Basel.

Organisations Organisation Basilea Pharmaceutica Ltd. (SIX: BSLN)
  Group Basilea (Group)
  Organisation 2 Astellas Pharma Inc. (TSE: 4503)
  Group Astellas (Group)
Products Product Zevtera™ (ceftobiprole medocaril)
  Product 2 isavuconazole
  Index term 2 Astellas–Basilea: antifungal, 201212– collab existent joint development of isavuconazole
Persons Person Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board)
  Person 2 Kaufhold, Achim (Basilea 201211 CMO before Affitech A/S + Pharmexa + Chiron + Berna Biotech + GSK)
     


   
Record changed: 2017-04-02

Advertisement

Picture [iito] – Putting Information into Context 600x60px

More documents for Basilea (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px




» top